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The expressed T cell repertoire to many proteins has been found to be focused
onto alimited numberofdiscrete immunodominant sitesrather than broadlydirected
at all segments of an antigen. The phenomenon has also been shown to occur for
noneukaryotic proteins, suchasinfluenzahemagglutinin (1), staphylococcalnuclease
(2), and R-galactosidase (3), that are unrelated to selfproteins ofthe mouse. There
appear to be several factors that influence the expressed repertoire to a particular
protein. The most clearly demonstrable influence is the MHC, and this appears to
be the basis ofIr gene effects, where differences in T cell responsiveness to protein
antigens occurbetweendifferent strains ofmice. Three majormechanisms have been
suggested by which MHC-linked genes may influence immune responsiveness (4).
Evidence has been obtained for a determinant selection mechanism by the demon-
stration ofdirect bindingofimmunodominant peptides to class II MHC restriction
molecules that can present the peptide but not to class II MHC molecules that do
notpresent the peptide (5, 6). There isalsosomeevidence forMHC-encodedmolecules
limiting the expressedrepertoire ofTcell clones during thymic development (hole-
in-the-repertoire model) (4), aswell as forMHC-linked Irgene-controlled responses
dominated by active suppression in low responder strains (7).
In this paper, we present evidence fora fourth major mechanism controlling the
expressed epitope repertoire andimmunodominance involving thespecificity ofan-
tigen processing and the existence ofhindering structures on naturally processed
fragments that differentially affect presentation bydifferent MHC molecules. Many
complex antigens, in contrast to short peptides, have been shown to require pro-
cessing by APCs before they can bepresented in an immunogenic form in associa-
tion with class II MHC to T helper cells (8). The molecular mechanisms involved
in processing are not fully understood. Processing can be inhibited by fixing APC
with paraformaldehyde or by treatment with agents such as chloroquine or ammo-
nium chloride, whichraise lysosomalandendosomalpH andinterferewithlysosomal
and endosomal function, and also with monensin, which inhibits receptor recycling
through the Golgi apparatus (8-10). Antigen processing was also inhibited by pro-
tease inhibitors such asleupeptin (9-11), suggesting processing involved proteolysis
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ofthe antigen into smaller fragments. However, some studies suggestedthat denatu-
ration (12) or unfolding (10) may be all that is necessary for processing of at least
some sites, and an unfolded portion offibrinogen didnot appear to require any pro-
cessing (13).
At the present time, however, little is known aboutthe chemical nature ofprocessed
antigen. There is some evidence that the hierarchy of T cell responses to different
determinants on an antigen maybe influenced by the particular forms of processed
antigen that occur. For example, in thehen egg lysozyme (HEL)' system, processing
differences have been suggested to explain the observations that the choice between
two distinct T cell determinants within a 23-amino acid region (Tll) depends on
their structural context (14). Also, with lysozyme, differential processing of variant
forms ofthe antigen appearsto result in theheteroclicityofB6 clones for ring-necked
pheasant lysosome (REL) in preference to HEL (15).
In the course of investigating the difference in immunogenicity and antigenicity
of whole sperm whale and equine myoglobin and synthetic peptide fragments of
theseproteins, we found two distinct linesof evidence that the choice ofTcell deter-
minants potentially available on complex protein antigens may not only be a func-
tion of Ia-peptide interaction but may also be related to processing events. Both
lines of evidence point to the existence of MHC-specific hindering structures on
naturally processed fragmentsthat are not presenton syntheticpeptides comprising
little more than the minimal antigenic site. First, after immunization with whole
equine or sperm whale myoglobin, different peptides became the focus of the re-
sponse in mice ofdifferent MHC haplotypes. However, individual clones were found
in myoglobin-immune mice that responded to peptides that did not stimulate a re-
sponse in the bulk immune lymph node T cell population. Moreover, immunization
with the peptides themselves revealed some new reactivities that had not appeared
after priming with whole myoglobin. In at least two cases, peptide immune T cells
appeared to be poorly crossreactive with whole myoglobin. Therefore, low respon-
siveness to these epitopes could be explained neither by the lack of an appropriate
T cell repertoire norby failure of the peptide to be presented by the class II MHC
molecules of that strain. A second independent line of evidence was the existence
ofTcell clones whose fine specificity forvariant sequenceswasdifferent when mea-
suredwith native proteins vs. syntheticpeptides. Thesestudiessuggestthat the struc-
ture of theantigenfragment resultingfrom natural processing is important, because
flanking regionsoutside theepitope mayinterfere with bindingto Ia or to theTCR.
This may have important implications for the design of peptide vaccines that, al-
though immunogenicthemselves, may generate a Tcell response that is poorly reac-
tive to the native molecule.
Materials and Methods
Myoglobin.
￿
Equine and spermwhale myoglobin were obtained from Accurate Chemical
and Scientific Co. (Hicksville, NY). Sperm whale myoglobin was purified by ion-exchange
chromatography by themethod of Hapner et al. (16), and the majorchromatographic com-
ponent, IV, was used for all studies.
Myoglobin Cleavage Fragments.
￿
Apo-myoglobinandCNBr cleavage fragmentsofequine myo-
globin were prepared as previously described (17).
1 Abbreviations used in this paper . HEL, hen egglysozyme; REL, ring-necked pheasant egglysozyme.BRETT ET AL .
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Peptide Synthesis .
￿
A nested series of peptides corresponding to region 102-118 of equine
and sperm whale myoglobin were prepared on a Vega 250 peptide synthesizer by using the
solid-phase method of Merrifield (18) as modified by Corley et al . (19) . The standard
t-boc/benzyl amino acid protection strategy was used with side chain protection of the fol-
lowing amino acids obtained from Vega Biochemicals (Tucson, AZ): Asp(O-benzyl), Glu-
(0-benzyl), His(tosyl), Lys(2-chlorobenzyloxycarbonyl), Ser(benzyl), and Tyr(2,6-
dichlorobenzyl) . The extent ofthe double dicyclohexylcarbodiimide-mediated couplings was
monitored using a qualitative ninhydrin test, and recoupling was performed when <99%
coupling was observed . Peptides were cleaved from the resin by using the standard high HF
method containing 10% p-cresol for 40min at 0°C, washed with ethyl acetate, and extracted
with acetic acid before lyophilizing . Peptides were purified to homogeneity by gel filtration
on a Biogel P4 column in9% formic acid and by reverse-phase HPLC described previously
(20). Composition was confirmed and concentration was determined by amino acid analysis
(kindly performed by Robert Boykins, FDA) . The peptides from the sperm whale sequence
were described previously (21) .
Mice.
￿
B10.BR (H-2k) and B10.D2 (H-2d) mice were obtained from The Jackson Labo-
ratory (Bar Harbor, ME) . BIOS (H-2$), B10.A(4R) (I-A k, I-E- ), (BIOS x B10.BR)F,, and
(BALB/c x A.SW)F, (H-2d x H-2')F l mice were bred in our own facility .
Lymph Node Proliferation Assays.
￿
Mice were immunized subcutaneously in the tail with 100
ug equine or sperm whale myoglobin in CFA. Alternatively, mice were immunized in the
same way with 4 nmol synthetic peptide . 8 d later, draining inguinal and periaortic lymph
nodes were removed, and single cell suspensions were prepared (22) . Assays were setup with
triplicate wells with appropriate antigen in 96-well plates with 3 .5 x 10 5 cells/well in com-
pletemedium consisting ofRPMI 1640 with 44% Eagle's-Hanks' amino acid medium, 10%
FCS, 5 x 10-5M 2-ME, 2 MM L-glutamine (Gibco Laboratories, Grand Island, NY), 100
U/ml penicillin, and 100 wg/ml streptomycin (Gibco Laboratories) . Plates were incubated
for 4 d at 37°C in 5% CO2 , pulsed with 1 pCi of [ 3H]thymidine (New England Nuclear,
Boston, MA), and harvested 18 h later onto glass fiber paper. [3H]thymidine incorporation
intoDNA was quantitated by liquid scintillation counting . The geometric mean and SEM
for each group were determined, and the no antigen background was subtracted to optain
A cpm .
Establishment ofMyoglobin-specific Lines and Clones .
￿
Equine myoglobin-specific polyclonal
lines were established by the method ofKimoto and Fathman (23) as modified by Matis et
al. (24) . Five mice were immunized in the footpad with 100 Pg equine myoglobin in CFA .
8 d later, draining inguinal and popliteal lymph nodes were removed, and the cell suspension
was enriched for T lymphocytes by passage over a nylon wool column. PurifiedT cells were
incubated at 4 x 106 cells/well in 24-well plates (No. 3524 ; Costar, Cambridge, MA) with
2 x 105 irradiated syngeneic spleen cells and equine myoglobin at 1 wM in complete tissue
culture medium (see above) . 4 d later, responding T blasts were purified by Ficoll density
gradient centrifugation . The T cells were put in resting culture at 2 x 105 cells/well with
4 x 106 irradiated spleen cells for 10 d ; then 5 x 106 irradiated spleen cells plus myoglobin
were added to begin another round of stimulation and rest . T cell lines were cloned by lim-
iting dilution after one or two rounds of stimulation and rest. The cloning was carried out
48 h after stimulation in the presence of antigen, 10 6 irradiated spleen cells, and 5 U/ml IL-
2-containing supernatant fromEL4Tlymphoma cells stimulated with mezerein . T cells were
cloned at 1 and 0.4 cells/well. Positive wells were expanded after 14 d into 24-well plates with
additional antigen, spleen cells, and IL-2 . After further expansion, cells werewashed, rested,
and-then stimulated without IL-2 in 2-wk cycles .
Proliferation Assay.
￿
Cloned T cells (10 1/0.2 ml) in microtiter wells containing various con-
centrations ofantigen with 5 x 105 irradiated syngeneic spleen cells asAPC were cultured for
4 d ; 1 pCi [ 3H]thymidine was added 18 h before harvesting. Results are expressed as geo-
metric mean t SEM of [3H]thymidine incorporation of triplicate wells.
Results
Previous studies have shown that B10.BR and BIOS mouse strains are both high
responders to equine myoglobin (25) . Using myoglobin sequence variants, residue360
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Proliferative responsesto equine
myoglobin-specific short-term polyclonal cell
lines from B10.BR and BIOS mice show
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109 was identified as being critical for stimulation ofBIOS T cells (26). In contrast,
a totally different crossreactivity pattern was observed for B10.BR T cells, as they
responded only to equine myoglobinand notto apanelof 16 othermyoglobins tested
(data not shown). To define more precisely the major determinants recognized by
thesetwo strains, synthetic peptides corresponding to different regions ofthe equine
myoglobin sequence were prepared and tested. Results in Fig. 1 show that the pep-
tide 102-118was able to stimulate equine myoglobin-immune BIOS T cells as effec-
tively as equine myoglobin itself, confirming that this region is immunodominant
for BIOS T cells. Because BIOS mice express only I-As and do not produce an I-E
molecule, it is likely that this peptide is presented in association with I-A'. In con-
trast to the results seen with BIOS T cells, the 102-118 region does not appear to
be stimulatory for B10.BR T cells immune to equine myoglobin. There was little
(<5%) or no detectable response to this peptide compared with equine myoglobin
in immune lymph node cultures (not shown) or short-term polyclonal cell lines (Fig.
1). Results in Fig. 1 also show that the short-term B10.BR polyclonal line had no
alloreactivity to B10.A(4R) cells, which express only I-A' . B10.A(4R) spleen cells
were able to present equine myoglobin to this line, although not as well as B10.BR
spleen cells, indicating that both I-A- and I-E-restricted T cells may be involved in
this response.
CloningRevealsEquineMyoglobin 102-118-specific B10.BR TCell Clones ofFine Specificity
Similarto Thosefrom BIO. SMice. A panel ofequine myoglobin-specific Tcell clones
established from BIOS and B10.BR mice were screened for reactivity to the 102-118
peptide. It was foundthat 16 of 17 BIOS clones responded to this peptide, confirming
the immunodominance of this region at the clonal level. These clones are probably
I-A3 restricted, because BIOS mice do not express an I-E molecule. Surprisingly,
3 of 16 equine myoglobin-specific clones from B10.BR mice also responded to the
102-118 peptide. The 102-118-specific BIO.BR clones were shown to be I-A' re-
stricted, because they responded on B10.A(4R) APC, which express only I-A' and
not I-Ek and because their response was blocked by the anti-I-A' mAb 10.2.16 but
not by the anti-I-El antibody 14.4.4.
It was surprising to find 3 of 16 oftheB10.BR clones responding to peptide 102-118,
becausevery little, ifany, response is observed to this peptide in thepolyclonal popu-
lation. It was therefore of interest to see if the fine specificity of these clones was
the same as that of 102-118-specific clones from BIOS mice, in which this peptide280
200
180
100
50
BRETT ET AL.
￿
361
A 1-4 E11/B10.S.
￿
B 10A10/810.BR
0.01
￿
0.1
￿
1.0
￿
0.1
￿
1 .0
ANTIGEN CONCENTRATION (pM)
FIGURE 2.
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Proliferative response of equine myoglobin-specific I-A9-restricted clone 1-4E11 (A)
and I-Ak-restricted clone 10A10 (B) to whole equine or sperm whale myoglobin or to synthetic
peptides corresponding to region 102-118 of these molecules. Culture conditions and results are
as in Fig. 1 . Background proliferation was <1,000 epm for both clones.
is immunodominant. Crossreactivity was assessed for sperm whale myoglobin and
for the 102-118 peptide therefrom, which differs from the equine sequence at two
residues, 109 and 118. The fine specificity of the BIOS clones showed three main
patterns with respect to the 102-118sw peptide. The majority of the clones (10 of
16) showed no responsiveness to either sperm whale myoglobin or 102-118sw and
corresponded to the predominant pattern observed in lymph node cultures and short-
term lines (26 and unpublished observations). Over one-third (6 of 16) of the clones,
however, showed some responsiveness to sperm whale myoglobin or the peptide (Fig.
2 A), but the degree ofcross-stimulation varied from clone to clone. The fine specificity
pattern of the B10.BR clones, such as 10A10, was of the latter type (Fig. 2 B). All
the I-Ak-restricted clones responded to 102-118sw, although this peptide was less po-
tent than the 102-118eq peptide. Variation in relative responsiveness among the three
clones indicated that these were distinct clones. Thus, overall, the B10.BR clones
specific for this region showed fine specificity similar to that of a significant fraction
of BIOS clones.
For the BIOS clones, the 102-118 peptide was 1 .5 to 3 times more potent than whole
myoglobin on a molar basis (Fig. 2 A). In contrast, for all the B10.BR clones, the
peptide was at least 10 times more potent than whole myoglobin (Fig. 2 B). To inves-
tigate whether these observations reflected differential antigen processing of equine
myoglobin by B10.BR and BIOS APC, the ability of the same APC, (B10.BR x
B10S)FI , to present whole equine myoglobin to the B10.BR and BIOS clones was
assessed. The F1 APC, which presented equine myoglobin to BIOS clones as well
as BIOS APC, did not present equine myoglobin to B10.BR T cell clones any better
than B10.BR APC did (Fig. 3). A similar result was found for other B10.BR and
BIOS clones as well. Thus, the inefficient presentation by B10.BR APC of this site
of equine myoglobin is not improved with the F1 APC that bear the I-A' molecule
capable of presenting this region of equine myoglobin more efficiently. We conclude
that the poor responsiveness to whole equine myoglobin versus peptide does not ap-
pear to be due to MHC-linked processing or the availability of all antigenic frag-362
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FIGURE 3. Test for an antigen-
processing defect in B10.tR vs.
BIOS or F1 APC. Proliferative re-
sponse of BIO.BR T cell clone
(1-1C4) andBIOS clone(1-4C1) to
equine myoglobinwhen incubated
withAPC from B10.BR(O), BIOS
("), and(B10.BR x B10S)FI (0)
mice. Proliferation stimulated by
102-118eq peptide on B10.BR (A)
orBIOS (A)APCisshownforcom-
parison. Background proliferation
was <1,000 rpm for all clones.
ments in different APC, but is dependenton the MHC molecule used for presenta-
tion. The response ofBIOS clones to wholemyoglobindoes not appear to be influenced
by thepresence of the I-A' haplotype in the FI macrophages, indicating that it exerts
no inhibitory or competitive effects. Also noteworthy, there was no degeneracy in
the ability of I-A' and I-As to crosspresent equine myoglobin to clones of the other
haplotype, although both I-A molecules can present the same site (Fig. 3).
Response of102-118eq Immune Lymph Node Cells Reveals a New Repertoire.
￿
Since 3
of 16 B10.BR clones obtained responded to the 102-118 region, it appeared that low
responsiveness of the polyclonal B10.BR T cells to this epitope was due neither to
an inability of I-A' to present this epitopenorto an absence of T cells in the reper-
toire. To further investigate the ability of B10.BR mice to respond to this region,
mice ofB10.BR andBIOS strainswere immunized with thesynthetic 102-118eq pep-
tide in CFA. Surprisingly, the peptide was immunogenic in both strains (Fig. 4).
However, whilethe 102-118eqBIOS immune Tcells responded as well to whole equine
myoglobin as they did to the peptide, B10.BR T cells responded to the peptide but
only very weakly to whole myoglobin. Also, whereas 102-118eq-specific BIOS T cells
were only weakly crossreactive to 102-118sw, corresponding to the overall pattern
observed in whole equine myoglobin-immune BIOS lymph node cells and most of
the T cell clones, 102-118eq-specific B10.BR T cells responded well to both equine
and sperm whale peptides. Because the backgrounds of the lymph node prolifera-
tion experimentstended to be high, ashort-term polyclonal line was established fromz 0
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FIGURE 4.
￿
Response of 102-118eq-specific lymphnode cells. Repertoire revealed on immuniza-
tion with peptide. Proliferative response of4 x 105unpurified lymphnode cells from BIOS and
B10.BR mice immunizedwith syntheticpeptide 102-118 ofthe equine sequence to various con-
centrations of whole equine or sperm whale myoglobin or peptides 102-118eq and 102-118sw.
Background cultures with medium alone were 19,678 cpm for BIOS cells and 16,897 cpm for
B10.BR cells. Results areplotted as geometric mean cpm of triplicate cultures (x/+ geometric
SEM). PPD responsesfor B10.BRcellswere 114,126(1.08) cpmandforBIOS were 162,434 (1.07)
cpm.
102-118-immune B10.BR lymph node cells. This line showed similar results to that
obtained with the lymph node cultures (Fig. 5). However, as the line was enriched
for antigen-specific T cells, the total response was enhanced. The increased sensi-
tivity allowed detection of the response to whole equine myoglobin, but there was
still a dramatic difference in the dose response to whole myoglobin versus peptide
(Fig. 5). The proliferative response of the 102-118eq B10.BR line was fully blocked
in the presence of an anti-I-Ak mAb (10.2.16) and not by an anti-I-Ek antibody
(14.4.4), suggesting that the majority of T cells in this line were I-Ak restricted (data
not shown). We are forced to conclude that I-A' can present this peptide and that
clones exist in the T cell repertoire specific forthis site. The lack of crossreactivity
forwholeequine myoglobin among peptide 102-118-immune T cellsin B10.BRmice
suggested an explanation for the low responsiveness to this epitope in equine myo-
globin-immune mice (see Discussion).
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FIGURE 5.
￿
Proliferative responseofshort-term B10.BRanti-
102-118eq T cell line to various concentrations of whole
equine or spermwhalemyoglobinofpeptides 102-118eqand
102-118sw. Background cultures with medium alone were
673 cpm.364
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Response ofH-2d Clone 9.27to Myoglobin Variant SyntheticPeptides But Not Whole Pro-
teins Provides a Second Line ofEvidence. Previous studies using sequence variants of
native myoglobin suggested that the site in native sperm whale myoglobin seen by
B10.D2 (H-2d)-immune lymph node cells and T cell clones included Glu 109 and
possibly His 116 (27). Usinganested series ofpeptides correspondingto region 102-118
ofsperm whale myoglobin, it was subsequently shown that these two residues were
indeed included in this immunodominant Tcell siterecognized in association with
I-Ad. A consensus sequence from 106-118 was required forstimulation ofthe clones
(21). Lack ofcrossreactivity with equine myoglobin was attributed to the substitu-
tion at position 109 ofAsp forGlu on the basis ofa panel of 15 variant myoglobins
(27). This was reconfirmed for clone 9.27 in the present study (data not shown).
It was therefore surprising to find that, forclone 9.27, the 102-118 peptideofequine
myoglobin was as potent as the spermwhalepeptide overawide dose-response range
in contrast to the response to the native proteins (Fig. 6). Other I-Ad-restricted
102-118-specific clones were examined, and while these all hardly responded to na-
tiveequine myoglobin, theyshowed differentdegrees ofresponsiveness tothe equine
peptide, as found with the B10.S clones. For example, clone 30-06 showed no re-
sponse tothe peptide, whereasclone 9.23 responded, butless well than to the sperm
so
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FIGURE 6.
￿
Crossreactivity at the peptide but not the pro-
tein level. Proliferative response ofclone 9.27 towhole equine
or sperm whale myoglobin orto synthetic peptides 102-118eq
and 102-118sw. Culture conditions and results are as in Fig.
1. Background proliferation was 385 cpm.
FIGURE 7.
￿
Prolifeative response ofclone 9.27 toequine
and sperm whale myoglobin, apo-equine myoglobin,
CNBr middle fragment (56-131), and synthetic peptide
102-118eq. Culture conditions andresults are as in Fig.
1. Background proliferation was 811 cpm.100
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FIGURE 8.
￿
Reactivity differences are
maintained in the same Fl APC.
Proliferative response of done 9.27 to
various concentrations of antigens
when incubated with APC from
BALB/c (H-2d), ASW (H-28
) (left),
and (BALB/c x ASW)Fl (right) mice.
Antigens tested were sperm whale and
equine myoglobin and peptides 102-
118sw and 102-118eq. Background
proliferation was <1,000 cpm for all
the medium alone controls.
whale peptide (data not shown). Parenthetically, this confirms and extends the results
reported by Cease et al. (21) that the response to this region represents focusing onto
an immunodominant site of T cells with a range of fine specificity patterns. How-
ever, the fact that many H-2d clones do not distinguish the equine and sperm whale
102-118 peptides as they do the native molecule provides a second line of evidence
that the processed form of the native molecules is hindered in its presentation or
recognition compared with the synthetic peptides.
Sperm Whale/EquineMyoglobinReactivity Differences InvolveOnly TCellsandAPC.
￿
Be-
cause the irradiated spleen cellsused as the source ofAPC are a heterogeneous popu-
lation comprising several cell types, the A20 (I-Ad) B cell lymphoma line was tested
to see ifthe difference between native sperm whale and equine myoglobinswas main-
tained. The results (not shown) indicate that when this line was used as an APC,
the difference in dose-response curves between native spermwhale and equine myo-
globins was maintained despite similar responses to the sperm whale and equine
peptides. Therefore, the differences are not due to regulatory cells contaminating
the APC source.
Differences Between Native Equine Myoglobin and Peptide Can Be Overcome by Artificial
Processing To determine the structural requirements for the reactivity differences
of equine peptide versus equine native myoglobin, the response ofclone 9.27 to apo-
equine myoglobin and the largest CNBr fragment (56-131) that contains the T cell
site was tested (Fig. 7). The responsiveness to apo-equine myoglobin was no greater
than that to native equine myoglobin. Thus, the release of the heme group with
some disruption oftertiary structure did not increase reactivity. However, the 56-131
CNBr fragment showed increased potency compared with the dose-response curve
for equine myoglobin. The results suggest that the reactivity differences between
equine peptide and native equine myoglobin may be due to lack of processing of
the native molecules to a fragment corresponding to the minimal site and to the
presence of structures on the naturally processed equine myoglobin that interfere
with binding to I-Ad or to the TCR of clone 9.27 .
Sperm Whale/Equine Myoglobin Reactivity Differences Are Maintained in the Same F1
APC. To determine whether the differences between spermwhale and equine myo-
globin, and between the equine peptide and native molecule, are due to processing366
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FIGURE 9.
￿
Proliferativeresponse ofsperm whalemyo-
globin-immune B10.D2lymphnode cellsto wholemyo-
globin or the 102-118 peptides. Lymph node cells (3.5
x 105) were cultured with various concentrations ofan-
tigen. Controlcultures without antigen gave 8798 (1.6)
cpm. PPDresponseswere 150,653 (1.05) cpmforsperm
whale-immune cells. Results are shown as A geometric
mean cpmof triplicate cultures (x /+ geometric SEM).
differences in APC of different H-2 haplotypes, the ability of APC from (H-2d x
H-2s)Ft mice to present both proteins to clone 9.27 was tested. The H-28 haplotype
was chosen because experiments above indicate that this strain is able to process
and present the 102-118 region of equine myoglobin efficiently. The reactivity differ-
ence between sperm whale and equine myoglobin and peptides was maintained in
the F1 APC (Fig. 8). No response was observed on H-2g APC either alone or in the
presence of any of the antigenic stimuli. These results suggest that differences in
the reactivities of sperm whale and equine myoglobin were not simply due to MHC-
linked processing or the availability of all antigenic fragments but were dependent
on the I-A molecule used in presentation.
Response ofSperm Whale Myoglobin-immune B10.D2 Lymph Node Cells to the 102-118
Region Indicates that Clone 9.27 Is Unusual But Not Unique. Further investigations were
carried out to determine whether the differential ability of clone 9.27 to recognize
whole sperm whale versus equine myoglobin compared with the peptides was related
to unique features of antigen recognition by this clone or reflected a generalized
inefficiency ofprocessing this site in equine myoglobin. B10.D2 mice were immunized
with equine or sperm whale myoglobin, and lymph node proliferative responses to
whole myoglobin and 102-118 peptides were assessed (Fig. 9). Results from sperm
whale-immune lymph node cells confirmed previous studies that the response in
this strain is predominantly directed to the 102-118 region, because this peptide was
as stimulatory as sperm whale myoglobin. In several experiments, there was only
a small response to equine myoglobin and a small but variable response to 102-118eq.
Thus, it appears that 9.27 is probably a less common but not unique clone in being
fully crossreactive at the peptide level.
Comparison ofNative Versus Peptide Responsefor OtherRpitopes.
￿
Results in the previous
sections indicate that responsiveness to a particulardeterminant may depend on the
structural environment ofthe determinant, as well as any intrinsic properties of the
site involved in la binding. We therefore extended the above studies by investigating
the crossreactivity with the native molecule after immunization with the different
peptides. Immunization of B10.D2 mice with native spermwhale myoglobin elicitsz
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FIGURE 10. Proliferative re-
8 132-1
￿
sponse of peptide-immune
lymph node cells from Bl0.D2
(H-2d) mice to whole sperm
whale myoglobin and peptides.
SwMb
￿
(A) mice immunized with 4
nmol of peptide 59-80; (B) mice
immunized with 4 nmol of
132-146. Culture conditions
1312-145 and expression of results as in
Fig. 4. Background cultures
gave 11,665 cpm for MOM cells
immune to59-80 and 5320 cpm
forB10.D2 cells immune topep-
0.3 1.0 3.0
￿
tide 132-146. PPD responses
were 68,517 and 57,484 cpm in
A and B, respectively.
a response predominantly to the 102-118 region, with only a small response to 59-80
and 132-146 (27-29). However, after immunization with the peptide 59-80, B10.D2
lymph node cells showed a good response to this peptide that was poorly recalled
by whole myoglobin (Fig. 10 A). In contrast, after immunization with peptide 132-146,
BMW (Fig. 10 B) and B10.S (not shown) T cells responded moderately well to the
whole protein as well as to the homologous peptide. The lymph node cellsappeared
to be specific for these peptides, because the peptides from other regions included
as controls did not stimulate above background levels.
Discussion
In this study we have provided two lines of evidence that antigen processing and
the structural environment of a T cell determinant may influence the magnitude
of the antigen-induced MHC-restricted proliferative response of T helper cells, the
immunodominance of particular epitopes, and even the apparent fine specificity of
isolated T cell clones. This may result from differences in processing between ho-
mologous proteins (such as equine or sperm whale myoglobin) or from structural
differences between the fragments of a protein produced by natural processing and
the synthetic peptides containing the core antigenic determinant. In the latter case,
even ifhomologous proteins are processed equivalently, the resulting fragments may
differ in hindering structures outside the core antigenic site. Such hindering struc-
tures in protein variants could account for the difference in response of clone 9.27
to native equine and spermwhale myoglobins, as well as for the heteroclicity of REL
compared with HEL cited above (15, 30).
The first line of evidence was that B10.BR mice, which appear to be T cell non-
responders to the 102-118 determinant after immunization with equine myoglobin,
turned out to be good responders to this site in association with I-A' after immuni-
zation with the synthetic 102-118 peptide. Thus, neither a gap in the T cell reper-
toire nor a failure of the epitope 102-118 itself to bind to Ak can account for the
low responsiveness to this site when H-2k mice are immunized with whole equine
myoglobin. Also, since monoclonal populations show the same differencein response
to whole myoglobin versus peptide, the difference cannot be due to suppressor T368
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cells specific for another epitope on the protein (30) . Therefore, we looked for an
alternative explanation. The difference in responsiveness to region 102-118 in B10.BR
mice after immunization with whole myoglobin or peptide may be related to the
requirement forprocessing ofthenative molecule.A comparison of the dose-response
curves to whole myoglobin versus peptideforindividual clones showed that, irrespective
of fine specificity, the native protein was only 1.5 to 3 times less potent on a molar
basis for BIOS clones compared with at least 10 times less potent for B10.BR clones .
This difference was also apparent for 102-118-immune BIOSand B10.BRlymph node
cells, because the B10.BR response, in contrast to the BIOS response, was not re-
called well by equine myoglobin in vitro . A similar observation recently has been
described with HEL, where immunization with peptide T11(74-96) induces a strong
proliferative response in B10.A mice, which is not recalled byHEL (30, 31) . Cultures
ofT cells from Tll-immune B10 mice, however, show excellent HEL-induced recall
under similar conditions (30, 31) .
In the myoglobin system, BIOS and B10.BR mice have the same B10 background
genes and would thereforebe expected to share identical non-MHCprocessing genes .
Since Fl APC presented whole equine myoglobin no better than B10.BR APC to
BIO.BRT cells, theobserved differenceswere not simply due to the generalized avail-
ability ofall antigenicfragments, asmight be expected if an MHC-linked processing
difference distinguished H-2k from H-23 . Rather, the difference depended on the
MHC restriction of the responding T cell . There has been some speculation that
Ia molecules themselves may guide processing by binding the immunogenic pep-
tides and somehow protecting them from furtherenzymatic digestion (32) . For this
to be the explanation for the results in the present study, peptides would have to
behandled differently byAPC and follow a differentintracellularpathwayfrom that
ofwhole proteins, perhaps avoiding lysosomal degradation enzymes . Amore likely
explanation, however, maybe that native myoglobin is processed down to an entity
larger than 102-118 and that flanking regions interfere with binding to I-Ak but not
to I-A3 . The interference maybe by steric hindrance or by an effect on peptide con-
formation . Theminimum length of the determinant is slightly different for BIOS
and B10.BR clones (102-115 for the former and 106-117 for the latter) (manuscript
in preparation) . Thus, hinderingstructures in the flanking regions surroundingthe
102-118 region in the naturally processed myoglobinproduct mayplay a major role
in reducing the affinity of binding to I-Ak but not to I-A5 , and therefore, such hin-
dering structures areMHC restricted .
Studies with the 102-118sw-specific I-Ad-restricted clone 9.27 provided the second
independentline of evidence that structural differences between equine and sperm
whale myoglobinthat areoutsidethe epitope itselfanddistinct from those minimally
necessaryfor recognition of peptide/Iamaycontribute to the differences in responses .
These differences may be related to the way murine APCs process equine versus
sperm whale myoglobin, but the Fl APC studies excluded actual MHC-linked
differences in processing. Alternatively, the two proteins may be processed equiva-
lently, but the natural product of processing equine myoglobin may contain hin-
dering structures that interfere with binding specifically toAd but not As or to the
receptors of specificT cells . Such hindering structures could also explain theheter-
oclitic response to REL compared with HEL by C57BL/6 mice (15, 30) . However,BRETT ET AL.
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in the latter case, sequence differences that influenced the response mapped outside
the antigenic site, whereas in the case of clone 9.27, the only critical difference be-
tween sperm whale and equine myoglobin that could be mapped with a panel of
15 sequence variants mapped to residue 109, within the minimal determinant 106-118
defined with peptides (27, 28). Nevertheless, at the peptide level, this clone did not
appear to discriminate between the sperm whale and equine sequences. This makes
it unlikely that the difference in responsiveness to sperm whale versus equine myo-
globin for this particular clone is related either to the fine specificity of the TCR
for the core antigenic site or to different binding affinitiesof the core antigenic site
for I-Ad, as is the case for cytochrome c (33). Because none of the H-2d T cells
specific for 102-118 responded well to native equine myoglobin, regardless of their
ability to discriminate Asp versus Glu at position 109 in the peptide, it is likely that
the postulated hindering structure interferes with binding to Ad rather than to the
specific receptor of clone 9.27. Alternatively, the hindering structure may bind to
the epitope itself, analogous to the distant residue of cytochrome c that has been
suggested to bind Lys 99 (34). Ifthis structure binds better to Asp 109 than to Glu
109, it could explain the mapping ofthe equine/sperm whale difference to residue 109.
Further immunizations with other peptides revealed some new reactivities that
had not appeared after priming with whole myoglobin. Most interesting was the
response to the 132-146 region of sperm whale myoglobin, which was -10% of the
response to 102-118 in myoglobin-immune lymphnode cultures (28, 35). Direct binding
studies have, however, demonstrated that 132-146 binds to its restriction molecule
(I-Ed) with as relatively high affinity as 102-118 binds to I-Ad (6). Immunization
with this peptide induced a good response to the peptide that was recalled well by
whole myoglobin in vitro. Therefore, in contrast to the observations described above
for the 102-118 site, there was apparently no difficulty in processing myoglobin to
produce a natural fragment that behaved similarly to the synthetic one. Previous
studies have demonstrated that the T cell response to sperm whale myoglobin is pri-
marily directed to 132-145 if APC that contain only I-Ed were used to stimulate
polyclonal T cells, but not if both I-Ad and I-Ed are present (28). If the two deter-
re on the same processed fragment, internal competition between the I-A
and I-E molecules for the same cleavage fragment may result, as also suggested by
Gammon et al. (30). In contrast, immunization with 59-80 did not elicit T cells
that crossreacted with the native molecule. This fragment ofspermwhale myoglobin
behaved in H-2d mice more like the equine 102-118 peptide in H-2kmice described
above.
These constraints on crossreactivity between native proteins and the corresponding
peptide epitopes, in cases where neither a gap in the T cell repertoire nor a failure
of the synthetic epitope to bind to the appropriate MHC molcule exists, indicate
that antigen processing may be another major mechanism determining Ir gene effects
and immunodominance. Taken together, the results can best be explained by the
stence ofMHC-specific hindering structures on the products ofnatural processing.
These structures and constraints will also be important in the development of syn-
thetic peptide vaccines to induce T cell immunity, because such vaccines must elicit
T cells that can crossreact with the native protein antigen as, for example, in recent
studies of hepatitis (36), malaria (37), and AIDS (38).370
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Summary
Two lines of evidence in the current study indicate that antigen processing is a
major factor, in addition to MHC binding and T cell repertoire, that determines
Ir gene responsiveness and epitope immunodominance. First, immunization with
synthetic peptides of myoglobin sequences revealed new reactivities that had not ap-
peared after priming with native myoglobin. For example, B10.S mice (H-23) im-
mune to equine myoglobin predominantly responded to peptide 102-118, whereas
there was little, if any, response to this peptide in B10.BR (H-2k) mice immunized
with native equine myoglobin. However, after immunization with the 102-118 pep-
tide, both strains responded to the peptide. After in vitro restimulation, B10.BR T
cells responded as well as B10.S T cells. Similarly, some individual 102-118-specific
T cell clones from mice of both haplotypes showed similar dose responses and fine
specificity patterns. Thus, low responsiveness to this site is due neither to a hole
in the repertoire nor to a failure to bind to the appropriate MHC molecule. An
alternative explanationwas suggestedby theobservation that, whereas B10.S T cells
from peptide 102-118-immune mice responded almost as well to whole myoglobin
as to the peptide, the B10.BR T cells from peptide immune mice, while responding
well to peptide, were poorly stimulated by whole myoglobin. Thus, the product of
natural processing of equine myoglobin probably has hindering structures in the
regions flanking the core epitope 102-118 that interfere with presentation by I-Ak
but not I-As.
The second line of evidence that processing of native myoglobin may influence
the apparent specificity of the T cell response was obtained using the I-Ad-restricted
sperm whale myoglobin 102-118-specific clone 9.27. This clonediscriminated readily
between whole sperm whalemyoglobin and equine myoglobin, butit did not distin-
guish between peptides corresponding to 102-118 of the sperm whale and equine
sequences. This distinction between equine peptide and native equine myoglobin
could be overcome by artificial "processing" ofequine myoglobinwith cyanogen bro-
mide. In both sets of experiments, Fl APCs that present the same epitope well to
T cells of another haplotype failed to overcome the defect, which was therefore not
due to the availability of different processed cleavage fragments in APC of different
haplotypes, as would be expected if there were MHC-linked processing. Thus, the
differential responses to peptides versus native molecule for both I-Ad- and I-Ak-
restricted clones appeared to depend on the restricting molecule used. The study
was extended to immunization of H-2d mice with peptides 59-80 and 132-146 of
sperm whale myoglobin, which also revealed new reactivities that were not a major
part of the response when priming with the native molecule, even though both pep-
tides bind with high affinity to I-Ad (39) and I-Ed (6), respectively. The 132-146-
immune T cells from B10.D2 and B10.S mice, in contrast to 102-118-immune T cells
from B10.BR mice, responded well to native myoglobin. Taken together, the results
suggest that the fragments produced by natural processing may bind Ia molecules
differently from thecorrespondingsyntheticpeptides. Theexistence ofMHC-restricted
hindering structures after natural processing may have important implications for
the development of synthetic peptide vaccines that, although immunogenic them-
selves, may notnecessarily elicit aresponse that crossreacts with thenative molecule.
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